IFIT3 specifically promotes pancreatic cancer cell metastasis by inhibiting IFIT2’s pro-apoptotic effects and upregulating vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) secretion (49, 50). This evidence concerns the gene VEGFA and familial pancreatic carcinoma.